Non Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Non Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Drug Development Pipeline Review, 2018

  • Report
  • 159 Pages
From
2018 Primary Sclerosing Cholangitis Drug Development- Pipeline Analysis Report - Product Thumbnail Image

2018 Primary Sclerosing Cholangitis Drug Development- Pipeline Analysis Report

  • Report
  • 48 Pages
From
Sickle Cell Disease Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Sickle Cell Disease Drug Development Pipeline Review, 2017

  • Report
  • 77 Pages
From
2018 Short Bowel Syndrome Drug Development- Pipeline Analysis Report - Product Thumbnail Image

2018 Short Bowel Syndrome Drug Development- Pipeline Analysis Report

  • Report
  • 45 Pages
From
2018 Eosinophilic Esophagitis Drug Development- Pipeline Analysis Report - Product Thumbnail Image

2018 Eosinophilic Esophagitis Drug Development- Pipeline Analysis Report

  • Report
  • 45 Pages
From
2018 Colitis Drug Development- Pipeline Analysis Report - Product Thumbnail Image

2018 Colitis Drug Development- Pipeline Analysis Report

  • Report
  • 70 Pages
From
Primary Sclerosing Cholangitis - Pipeline Review, H1 2018 - Product Thumbnail Image

Primary Sclerosing Cholangitis - Pipeline Review, H1 2018

  • Report
  • 106 Pages
From
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H1 2018 - Product Thumbnail Image

Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H1 2018

  • Report
  • 237 Pages
From
Non-Alcoholic Steatohepatitis (NASH) - Pipeline Review, H1 2018 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) - Pipeline Review, H1 2018

  • Report
  • 512 Pages
From
Non-Alcoholic Steatohepatitis (NASH) - Pipeline Review, H2 2017 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) - Pipeline Review, H2 2017

  • Report
  • 446 Pages
From
Primary Sclerosing Cholangitis - Pipeline Review, H2 2017 - Product Thumbnail Image

Primary Sclerosing Cholangitis - Pipeline Review, H2 2017

  • Report
  • 91 Pages
From
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H2 2017 - Product Thumbnail Image

Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H2 2017

  • Report
  • 202 Pages
From
Non-Alcoholic Steatohepatitis - Pipeline Review, H1 2017 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis - Pipeline Review, H1 2017

  • Report
  • 402 Pages
From
Global Sickle Cell Anemia Drug Market, Price, Dosage & Clinical Pipeline Outlook 2024 - Product Thumbnail Image

Global Sickle Cell Anemia Drug Market, Price, Dosage & Clinical Pipeline Outlook 2024

  • Report
  • 170 Pages
From
Sickle Cell Disease - Pipeline Review, H1 2018 - Product Thumbnail Image

Sickle Cell Disease - Pipeline Review, H1 2018

  • Report
  • 211 Pages
From
Sickle Cell Disease - Pipeline Insight, 2018 - Product Thumbnail Image

Sickle Cell Disease - Pipeline Insight, 2018

  • Drug Pipelines
  • 142 Pages
From
Free Fatty Acid Receptor 4 - Pipeline Review, H2 2017 - Product Thumbnail Image

Free Fatty Acid Receptor 4 - Pipeline Review, H2 2017

  • Report
  • 29 Pages
From
Free Fatty Acid Receptor 4 - Pipeline Review, H1 2017 - Product Thumbnail Image

Free Fatty Acid Receptor 4 - Pipeline Review, H1 2017

  • Report
  • 31 Pages
From
Hypertriglyceridemia - Pipeline Review, H2 2016 - Product Thumbnail Image

Hypertriglyceridemia - Pipeline Review, H2 2016

  • Report
  • 113 Pages
From
Hypertriglyceridemia - Pipeline Review, H1 2016 - Product Thumbnail Image

Hypertriglyceridemia - Pipeline Review, H1 2016

  • Report
  • 106 Pages
From
Loading Indicator
adroll